CIPLA - Cipla Limited

Cipla Limited Share Market Related News
-: Stock News :- CIPLA 17-06-2022 To 17-06-2022
-: Stock News :- CIPLA 17-06-2022 To 17-06-2022

✔️ Cipla to acquire 21% stake in diagnostic company Achira Labs for Rs 25 cr

View Full Story
-: Stock News :- CIPLA 02-06-2022 To 02-06-2022
-: Stock News :- CIPLA 02-06-2022 To 02-06-2022

✔️ Cipla adds capacity of captive renewable energy power plant in Maharashtra, Karnataka

View Full Story
-: Stock News :- CIPLA 20-05-2022 To 20-05-2022
-: Stock News :- CIPLA 20-05-2022 To 20-05-2022

✔️ Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key

View Full Story
-: Stock News :- CIPLA 19-05-2022 To 19-05-2022
-: Stock News :- CIPLA 19-05-2022 To 19-05-2022

✔️ Rejuvenating Cipla: After global expansion, acquisitions on cards

View Full Story
-: Stock News :- CIPLA 12-05-2022 To 12-05-2022
-: Stock News :- CIPLA 12-05-2022 To 12-05-2022

✔️ Buy Cipla; target of Rs 1095: ICICI Direct
✔️ Neutral Cipla; target of Rs 880: Motilal Oswal
✔️ Buy Cipla; target of Rs 1085: Prabhudas Lilladher
✔️ Buy Cipla: target of Rs 1150: Sharekhan
✔️ Cipla: Targets for US complex generics on track
✔️ Cipla looks to invest more in mRNA tech; holds discussions with firms

View Full Story
-: Stock News :- CIPLA 11-05-2022 To 10-05-2022
-: Stock News :- CIPLA 11-05-2022 To 10-05-2022

✔️ Cipla will use Covid-19 bulk drugs inventory when demand rises
✔️ Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
✔️ As Cipla falls after earnings, should you buy or sell stock?
✔️ Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 20-04-2022 To 10-05-2022
-: Stock News :- CIPLA 20-04-2022 To 10-05-2022

✔️ Cost pressure likely to weigh on pharma companies' margins in Q4
✔️ Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
✔️ As Cipla falls after earnings, should you buy or sell stock?
✔️ Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 14-04-2022 To 10-05-2022
-: Stock News :- CIPLA 14-04-2022 To 10-05-2022

✔️ Cipla Q4 PAT seen up 27.6% YoY to Rs 527.6 cr: Prabhudas Lilladher
✔️ Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
✔️ As Cipla falls after earnings, should you buy or sell stock?
✔️ Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 13-04-2022 To 10-05-2022
-: Stock News :- CIPLA 13-04-2022 To 10-05-2022

✔️ Cipla’s India business drives growth, key product launches in pipeline
✔️ Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
✔️ As Cipla falls after earnings, should you buy or sell stock?
✔️ Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 01-04-2022 To 10-05-2022
-: Stock News :- CIPLA 01-04-2022 To 10-05-2022

✔️ Buy Cipla: target of Rs 1150: Sharekhan
✔️ Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
✔️ As Cipla falls after earnings, should you buy or sell stock?
✔️ Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 29-03-2022 To 10-05-2022
-: Stock News :- CIPLA 29-03-2022 To 10-05-2022

✔️ BS Awards for Corporate Excellence 2021: Samina Hamied lauds team effort
✔️ Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
✔️ As Cipla falls after earnings, should you buy or sell stock?
✔️ Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 15-03-2022 To 10-05-2022
-: Stock News :- CIPLA 15-03-2022 To 10-05-2022

✔️ Cipla hits fresh all-time high in a volatile market; rallies 12% in 1 week
✔️ Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
✔️ As Cipla falls after earnings, should you buy or sell stock?
✔️ Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 11-03-2022 To 10-05-2022
-: Stock News :- CIPLA 11-03-2022 To 10-05-2022

✔️ Cipla gains 3%, hits record high; trades higher for 5th straight day
✔️ Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
✔️ As Cipla falls after earnings, should you buy or sell stock?
✔️ Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 15-02-2022 To 10-05-2022
-: Stock News :- CIPLA 15-02-2022 To 10-05-2022

✔️ Two Cipla promoters sell 20 mn shares; promoter group now holds 34.23%
✔️ Cipla slips 5% as 2.5% equity change hands on the BSE
✔️ Cipla's stock falls on promoters block deal to offload minority stake
✔️ Cipla promoters to sell up to 2.5% stake in block deal
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 04-02-2022 To 10-05-2022
-: Stock News :- CIPLA 04-02-2022 To 10-05-2022

✔️ Cipla: Kedar Upadhye resigns as Global CFO to pursue career beyond pharma
✔️ Cipla slips 5% as 2.5% equity change hands on the BSE
✔️ Cipla's stock falls on promoters block deal to offload minority stake
✔️ Cipla promoters to sell up to 2.5% stake in block deal
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 02-02-2022 To 10-05-2022
-: Stock News :- CIPLA 02-02-2022 To 10-05-2022

✔️ Accumulate Cipla; target of Rs 998: KR Choksey
✔️ Cipla slips 5% as 2.5% equity change hands on the BSE
✔️ Cipla's stock falls on promoters block deal to offload minority stake
✔️ Cipla promoters to sell up to 2.5% stake in block deal
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 29-01-2022 To 10-05-2022
-: Stock News :- CIPLA 29-01-2022 To 10-05-2022

✔️ Buy Cipla; target of Rs 1100: ICICI Direct
✔️ Most brokerages bullish on Cipla; Cite US, local market growth potential
✔️ Cipla Consolidated December 2021 Net Sales at Rs 5,478.86 crore, up 6% Y-o-Y
✔️ Cipla promoters to sell up to 2.5% stake in block deal
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 27-01-2022 To 10-05-2022
-: Stock News :- CIPLA 27-01-2022 To 10-05-2022

✔️ What should investors do with Cipla post Q3 earnings; buy, sell or hold?
✔️ Naina Lal Kidwai Resigns From Cipla Board
✔️ Naina Lal Kidwai resigns from Cipla board
✔️ Cipla promoters to sell up to 2.5% stake in block deal
✔️ Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact
✔️ Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates
✔️ Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates
✔️ Cipla Results Preview | Consolidated net profit may rise 47% on India ops
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 26-01-2022 To 10-05-2022
-: Stock News :- CIPLA 26-01-2022 To 10-05-2022

✔️ Multiple triggers across key markets may support Cipla's recent rally
✔️ Cipla's Q3 performance better than expected on strong show in India, US
✔️ Cipla Consolidated December 2021 Net Sales at Rs 5,478.86 crore, up 6% Y-o-Y
✔️ Cipla Q3 PAT dips 2.6% at Rs 729 crore
✔️ Cipla Q3 Profit Dips 2.6% To Rs 729 Crore
✔️ Cipla Q3 results: Consolidated PAT falls marginally to Rs 729 cr
✔️ Cipla Q3 results | Profit falls 2.6% YoY to Rs 729 crore, revenue grows to Rs 5,479 crore
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 13-01-2022 To 10-05-2022
-: Stock News :- CIPLA 13-01-2022 To 10-05-2022

✔️ Cipla Q3 PAT may dip 6.4% YoY to Rs 700.3 cr: Prabhudas Lilladher
✔️ Cipla's Q3 performance better than expected on strong show in India, US
✔️ Cipla Consolidated December 2021 Net Sales at Rs 5,478.86 crore, up 6% Y-o-Y
✔️ Cipla Q3 PAT dips 2.6% at Rs 729 crore
✔️ Cipla Q3 Profit Dips 2.6% To Rs 729 Crore
✔️ Cipla Q3 results: Consolidated PAT falls marginally to Rs 729 cr
✔️ Cipla Q3 results | Profit falls 2.6% YoY to Rs 729 crore, revenue grows to Rs 5,479 crore
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 12-01-2022 To 10-05-2022
-: Stock News :- CIPLA 12-01-2022 To 10-05-2022

✔️ InvaGen to continue to hold shares in Avenue Therapeutics: Cipla
✔️ Cipla's Q3 performance better than expected on strong show in India, US
✔️ Cipla Consolidated December 2021 Net Sales at Rs 5,478.86 crore, up 6% Y-o-Y
✔️ Cipla Q3 PAT dips 2.6% at Rs 729 crore
✔️ Cipla Q3 Profit Dips 2.6% To Rs 729 Crore
✔️ Cipla Q3 results: Consolidated PAT falls marginally to Rs 729 cr
✔️ Cipla Q3 results | Profit falls 2.6% YoY to Rs 729 crore, revenue grows to Rs 5,479 crore
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 28-12-2021 To 10-05-2022
-: Stock News :- CIPLA 28-12-2021 To 10-05-2022

✔️ Torrent, Cipla, Sun announce branded versions of molnupiravir in India
✔️ Cipla gets EUA from DCGI to market Molnupiravir for COVID-19 treatment
✔️ Cipla receives EUA for oral antiviral drug to treat mild-to-moderate Covid
✔️ Cipla to launch oral anti-viral covid drug Molnupiravir in India
✔️ Cipla Q3 Profit Dips 2.6% To Rs 729 Crore
✔️ Cipla Q3 results: Consolidated PAT falls marginally to Rs 729 cr
✔️ Cipla Q3 results | Profit falls 2.6% YoY to Rs 729 crore, revenue grows to Rs 5,479 crore
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 27-12-2021 To 10-05-2022
-: Stock News :- CIPLA 27-12-2021 To 10-05-2022

✔️ Hot Stocks | Here's why you should bet on Cipla, Coforge in near term
✔️ Cipla gets EUA from DCGI to market Molnupiravir for COVID-19 treatment
✔️ Cipla receives EUA for oral antiviral drug to treat mild-to-moderate Covid
✔️ Cipla to launch oral anti-viral covid drug Molnupiravir in India
✔️ Cipla Q3 Profit Dips 2.6% To Rs 729 Crore
✔️ Cipla Q3 results: Consolidated PAT falls marginally to Rs 729 cr
✔️ Cipla Q3 results | Profit falls 2.6% YoY to Rs 729 crore, revenue grows to Rs 5,479 crore
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 20-12-2021 To 10-05-2022
-: Stock News :- CIPLA 20-12-2021 To 10-05-2022

✔️ Cipla stock rises on strong launch pipeline, FDA approval for injection
✔️ Market Movers: Why Cipla shined and retail investor honeymoon is over?
✔️ For Cipla, surprise product approval in the US brings cheers to investors
✔️ Cipla gains 3% on USFDA's final approval for Lanreotide injection
✔️ Cipla receives USFDA nod to market Lanreotide injection in US market
✔️ Cipla receives final approval for Lanreotide Injection. Details here
✔️ Cipla gets USFDA approval to market Lanreotide injection in US market
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 15-12-2021 To 10-05-2022
-: Stock News :- CIPLA 15-12-2021 To 10-05-2022

✔️ Drug major Cipla to acquire 33% stake in Clean Max Auriga Power
✔️ Cipla acquires 33% stake in Clean Max Auriga Power
✔️ For Cipla, surprise product approval in the US brings cheers to investors
✔️ Cipla gains 3% on USFDA's final approval for Lanreotide injection
✔️ Cipla receives USFDA nod to market Lanreotide injection in US market
✔️ Cipla receives final approval for Lanreotide Injection. Details here
✔️ Cipla gets USFDA approval to market Lanreotide injection in US market
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 17-11-2021 To 10-05-2022
-: Stock News :- CIPLA 17-11-2021 To 10-05-2022

✔️ Cipla introduces portable wireless spirometer for diagnosis of COPD, asthma
✔️ Cipla acquires 33% stake in Clean Max Auriga Power
✔️ For Cipla, surprise product approval in the US brings cheers to investors
✔️ Cipla gains 3% on USFDA's final approval for Lanreotide injection
✔️ Cipla receives USFDA nod to market Lanreotide injection in US market
✔️ Cipla receives final approval for Lanreotide Injection. Details here
✔️ Cipla gets USFDA approval to market Lanreotide injection in US market
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 16-11-2021 To 10-05-2022
-: Stock News :- CIPLA 16-11-2021 To 10-05-2022

✔️ Cipla to be added to Dow Jones Sustainability Index for emerging markets
✔️ Cipla acquires 33% stake in Clean Max Auriga Power
✔️ For Cipla, surprise product approval in the US brings cheers to investors
✔️ Cipla gains 3% on USFDA's final approval for Lanreotide injection
✔️ Cipla receives USFDA nod to market Lanreotide injection in US market
✔️ Cipla receives final approval for Lanreotide Injection. Details here
✔️ Cipla gets USFDA approval to market Lanreotide injection in US market
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 03-11-2021 To 10-05-2022
-: Stock News :- CIPLA 03-11-2021 To 10-05-2022

✔️ Cipla: With the Covid-19 drugs boost gone, can this pharma giant still shine?
✔️ Cipla unit gets notice from US firm for termination of acquisition deal
✔️ For Cipla, surprise product approval in the US brings cheers to investors
✔️ Cipla gains 3% on USFDA's final approval for Lanreotide injection
✔️ Cipla receives USFDA nod to market Lanreotide injection in US market
✔️ Cipla receives final approval for Lanreotide Injection. Details here
✔️ Cipla gets USFDA approval to market Lanreotide injection in US market
✔️ Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 27-10-2021 To 10-05-2022
-: Stock News :- CIPLA 27-10-2021 To 10-05-2022

✔️ Cipla's 'core' growth offsets weak show in US, Covid portfolio
✔️ Cipla Standalone September 2021 Net Sales at Rs 3,935.03 crore, up 3.34% Y-o-Y
✔️ Cipla's decent Q2 performance provides confidence on forward prospects
✔️ Cipla Q2 results: Net profit rises 7% to Rs 711 cr, revenue up 10%
✔️ Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth
✔️ Cipla Records Rs 712 Crore Net Profit In September Quarter
✔️ Cipla Q2 Result | Profit comes in at Rs 711 crore, revenue at Rs 5,520 crore
✔️ Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 06-10-2021 To 10-05-2022
-: Stock News :- CIPLA 06-10-2021 To 10-05-2022

✔️ Cipla Q2 PAT seen up 20.3% YoY to Rs 793.4 cr: Prabhudas Lilladher
✔️ Cipla Standalone September 2021 Net Sales at Rs 3,935.03 crore, up 3.34% Y-o-Y
✔️ Cipla's decent Q2 performance provides confidence on forward prospects
✔️ Cipla Q2 results: Net profit rises 7% to Rs 711 cr, revenue up 10%
✔️ Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth
✔️ Cipla Records Rs 712 Crore Net Profit In September Quarter
✔️ Cipla Q2 Result | Profit comes in at Rs 711 crore, revenue at Rs 5,520 crore
✔️ Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 04-10-2021 To 10-05-2022
-: Stock News :- CIPLA 04-10-2021 To 10-05-2022

✔️ Cipla to sell Eli Lilly's Trulicity, Humalog diabetes treatments in India
✔️ Eli Lilly to transfer rights of two diabetes products to Cipla
✔️ Cipla to sell Lilly's Trulicity, Humalog diabetes treatments in India
✔️ Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India
✔️ Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth
✔️ Cipla Records Rs 712 Crore Net Profit In September Quarter
✔️ Cipla Q2 Result | Profit comes in at Rs 711 crore, revenue at Rs 5,520 crore
✔️ Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 01-10-2021 To 10-05-2022
-: Stock News :- CIPLA 01-10-2021 To 10-05-2022

✔️ Cipla eyes acquisitions in India, US after Covid-led windfall
✔️ Cipla's shares echo investors' bet on sustained core growth
✔️ Cipla to sell Lilly's Trulicity, Humalog diabetes treatments in India
✔️ Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India
✔️ Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth
✔️ Cipla Records Rs 712 Crore Net Profit In September Quarter
✔️ Cipla Q2 Result | Profit comes in at Rs 711 crore, revenue at Rs 5,520 crore
✔️ Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 07-09-2021 To 10-05-2022
-: Stock News :- CIPLA 07-09-2021 To 10-05-2022

✔️ Cipla seeks price hike for certain respiratory medications, writes to NPPA
✔️ Cipla's shares echo investors' bet on sustained core growth
✔️ Cipla to sell Lilly's Trulicity, Humalog diabetes treatments in India
✔️ Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India
✔️ Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth
✔️ Cipla Records Rs 712 Crore Net Profit In September Quarter
✔️ Cipla Q2 Result | Profit comes in at Rs 711 crore, revenue at Rs 5,520 crore
✔️ Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 25-08-2021 To 10-05-2022
-: Stock News :- CIPLA 25-08-2021 To 10-05-2022

✔️ Cipla partners Kemwell to foray into respiratory biosimilars space
✔️ Cipla, Kemwell Biopharma enter JV to develop biosimilars
✔️ Cipla, Kemwell Biopharma form JV for developing, manufacturing biosimilars
✔️ Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India
✔️ Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth
✔️ Cipla Records Rs 712 Crore Net Profit In September Quarter
✔️ Cipla Q2 Result | Profit comes in at Rs 711 crore, revenue at Rs 5,520 crore
✔️ Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 12-08-2021 To 10-05-2022
-: Stock News :- CIPLA 12-08-2021 To 10-05-2022

✔️ Cipla gets USFDA nod for generic product
✔️ Cipla, Kemwell Biopharma enter JV to develop biosimilars
✔️ Cipla, Kemwell Biopharma form JV for developing, manufacturing biosimilars
✔️ Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India
✔️ Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth
✔️ Cipla Records Rs 712 Crore Net Profit In September Quarter
✔️ Cipla Q2 Result | Profit comes in at Rs 711 crore, revenue at Rs 5,520 crore
✔️ Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 10-08-2021 To 10-05-2022
-: Stock News :- CIPLA 10-08-2021 To 10-05-2022

✔️ Buy Cipla; target of Rs 1205: ICICI Direct
✔️ Cipla CFO says drug maker to outperform domestic market in FY22, Moderna vaccine import may take time
✔️ Cipla, Kemwell Biopharma form JV for developing, manufacturing biosimilars
✔️ Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India
✔️ Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth
✔️ Cipla Records Rs 712 Crore Net Profit In September Quarter
✔️ Cipla Q2 Result | Profit comes in at Rs 711 crore, revenue at Rs 5,520 crore
✔️ Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts
✔️ Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit
✔️ Cipla launches real-time RT-PCR test kit for COVID-19
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 06-08-2021 To 10-05-2022
-: Stock News :- CIPLA 06-08-2021 To 10-05-2022

✔️ Buzzing Stocks: Rate-sensitives, Cipla, RIL and other stocks in news today
✔️ Cipla Consolidated June 2021 Net Sales at Rs 5,504.35 crore, up 26.65% Y-o-Y
✔️ Cipla's domestic formulation biz drives Q1 show; outlook remains firm
✔️ What should investors do with Cipla post Q1 earnings: buy, sell or hold?
✔️ Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
✔️ Cipla Q1 net profit up 25% to Rs 709.92 crore
✔️ Cipla Q1 results: Net profit rises 25% to 709.92 cr
✔️ Top headlines: Govt buries retro tax; Cipla Q1 net profit rises 24%
✔️ Cipla posts 24% YoY net profit growth in Q1FY22 led by core therapies, COVID portfolio
✔️ Cipla's Q1 PAT grows 24% to Rs 715 crore riding on domestic sales
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 13-07-2021 To 10-05-2022
-: Stock News :- CIPLA 13-07-2021 To 10-05-2022

✔️ Cipla Q1 PAT seen up 10.9% YoY to Rs 640.7 cr: KRChoksey
✔️ Cipla Consolidated June 2021 Net Sales at Rs 5,504.35 crore, up 26.65% Y-o-Y
✔️ Cipla's domestic formulation biz drives Q1 show; outlook remains firm
✔️ What should investors do with Cipla post Q1 earnings: buy, sell or hold?
✔️ Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
✔️ Cipla Q1 net profit up 25% to Rs 709.92 crore
✔️ Cipla Q1 results: Net profit rises 25% to 709.92 cr
✔️ Top headlines: Govt buries retro tax; Cipla Q1 net profit rises 24%
✔️ Cipla posts 24% YoY net profit growth in Q1FY22 led by core therapies, COVID portfolio
✔️ Cipla's Q1 PAT grows 24% to Rs 715 crore riding on domestic sales
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 12-07-2021 To 10-05-2022
-: Stock News :- CIPLA 12-07-2021 To 10-05-2022

✔️ Cipla Health expands hand and surface sanitation range
✔️ Cipla Consolidated June 2021 Net Sales at Rs 5,504.35 crore, up 26.65% Y-o-Y
✔️ Cipla's domestic formulation biz drives Q1 show; outlook remains firm
✔️ What should investors do with Cipla post Q1 earnings: buy, sell or hold?
✔️ Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
✔️ Cipla Q1 net profit up 25% to Rs 709.92 crore
✔️ Cipla Q1 results: Net profit rises 25% to 709.92 cr
✔️ Top headlines: Govt buries retro tax; Cipla Q1 net profit rises 24%
✔️ Cipla posts 24% YoY net profit growth in Q1FY22 led by core therapies, COVID portfolio
✔️ Cipla's Q1 PAT grows 24% to Rs 715 crore riding on domestic sales
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 09-07-2021 To 10-05-2022
-: Stock News :- CIPLA 09-07-2021 To 10-05-2022

✔️ Street bets on Cipla's respiratory drug portfolio to drive growth
✔️ Cipla Consolidated June 2021 Net Sales at Rs 5,504.35 crore, up 26.65% Y-o-Y
✔️ Cipla's domestic formulation biz drives Q1 show; outlook remains firm
✔️ What should investors do with Cipla post Q1 earnings: buy, sell or hold?
✔️ Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
✔️ Cipla Q1 net profit up 25% to Rs 709.92 crore
✔️ Cipla Q1 results: Net profit rises 25% to 709.92 cr
✔️ Top headlines: Govt buries retro tax; Cipla Q1 net profit rises 24%
✔️ Cipla posts 24% YoY net profit growth in Q1FY22 led by core therapies, COVID portfolio
✔️ Cipla's Q1 PAT grows 24% to Rs 715 crore riding on domestic sales
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 08-07-2021 To 10-05-2022
-: Stock News :- CIPLA 08-07-2021 To 10-05-2022

✔️ Discussions still going on over indemnity to Moderna, says report
✔️ Cipla Consolidated June 2021 Net Sales at Rs 5,504.35 crore, up 26.65% Y-o-Y
✔️ Cipla's domestic formulation biz drives Q1 show; outlook remains firm
✔️ What should investors do with Cipla post Q1 earnings: buy, sell or hold?
✔️ Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
✔️ Cipla Q1 net profit up 25% to Rs 709.92 crore
✔️ Cipla Q1 results: Net profit rises 25% to 709.92 cr
✔️ Top headlines: Govt buries retro tax; Cipla Q1 net profit rises 24%
✔️ Cipla posts 24% YoY net profit growth in Q1FY22 led by core therapies, COVID portfolio
✔️ Cipla's Q1 PAT grows 24% to Rs 715 crore riding on domestic sales
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 30-06-2021 To 10-05-2022
-: Stock News :- CIPLA 30-06-2021 To 10-05-2022

✔️ Cipla, Dr Reddy's Labs: Tech charts show up to 11% rally in pharma stocks
✔️ Cipla records fresh highs on nod for Moderna's Covid-19 vaccine
✔️ The daily dose: June 30, 2021
✔️ Cipla hits new high on DCGI nod to import Moderna vaccine; up 4% in 2 days
✔️ Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
✔️ Cipla Q1 net profit up 25% to Rs 709.92 crore
✔️ Cipla Q1 results: Net profit rises 25% to 709.92 cr
✔️ Top headlines: Govt buries retro tax; Cipla Q1 net profit rises 24%
✔️ Cipla posts 24% YoY net profit growth in Q1FY22 led by core therapies, COVID portfolio
✔️ Cipla's Q1 PAT grows 24% to Rs 715 crore riding on domestic sales
✔️ Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

View Full Story
-: Stock News :- CIPLA 29-06-2021 To 29-06-2021
-: Stock News :- CIPLA 29-06-2021 To 29-06-2021

✔️ Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet
✔️ Moderna's Covid vaccine gets nod for restricted use
✔️ Cipla says doesn't have definitive pact on commercial supplies of Moderna vaccine
✔️ Cipla gets authorisation for restricted use in India of donated Moderna vaccines
✔️ Cipla gets regulator nod to import Moderna's Covid-19 vaccine
✔️ Cipla gets DCGI nod to import Moderna COVID-19 vaccine
✔️ Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
✔️ Cipla gets nod to import Moderna's covid vaccine for emergency use in India: Report
✔️ India's drug regulator may soon approve Moderna's vaccine: Report
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 23-06-2021 To 29-06-2021
-: Stock News :- CIPLA 23-06-2021 To 29-06-2021

✔️ Cipla receives USFDA nod for Arformoterol Tartrate Inhalation Solution
✔️ Cipla gets USFDA nod for inhalation product
✔️ Cipla says doesn't have definitive pact on commercial supplies of Moderna vaccine
✔️ Cipla gets authorisation for restricted use in India of donated Moderna vaccines
✔️ Cipla gets regulator nod to import Moderna's Covid-19 vaccine
✔️ Cipla gets DCGI nod to import Moderna COVID-19 vaccine
✔️ Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
✔️ Cipla gets nod to import Moderna's covid vaccine for emergency use in India: Report
✔️ India's drug regulator may soon approve Moderna's vaccine: Report
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 12-06-2021 To 29-06-2021
-: Stock News :- CIPLA 12-06-2021 To 29-06-2021

✔️ Why you should continue holding Cipla stock
✔️ Cipla gets USFDA nod for inhalation product
✔️ Cipla says doesn't have definitive pact on commercial supplies of Moderna vaccine
✔️ Cipla gets authorisation for restricted use in India of donated Moderna vaccines
✔️ Cipla gets regulator nod to import Moderna's Covid-19 vaccine
✔️ Cipla gets DCGI nod to import Moderna COVID-19 vaccine
✔️ Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
✔️ Cipla gets nod to import Moderna's covid vaccine for emergency use in India: Report
✔️ India's drug regulator may soon approve Moderna's vaccine: Report
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 01-06-2021 To 29-06-2021
-: Stock News :- CIPLA 01-06-2021 To 29-06-2021

✔️ Anand Mahindra calls Cipla-Moderna COVID-19 vaccine deal 'good news'; hopes for exemptions
✔️ Cipla close to committing $1 billion advance for Moderna COVID-19 booster vaccine in India
✔️ Cipla says close to committing $1 billion to Moderna for booster vaccine
✔️ Close to commit over $1-b to Moderna for booster vaccine: Cipla to Govt
✔️ Cipla to market Delhi start-up's waterless' hygiene products
✔️ Cipla gets DCGI nod to import Moderna COVID-19 vaccine
✔️ Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
✔️ Cipla gets nod to import Moderna's covid vaccine for emergency use in India: Report
✔️ India's drug regulator may soon approve Moderna's vaccine: Report
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 27-05-2021 To 29-06-2021
-: Stock News :- CIPLA 27-05-2021 To 29-06-2021

✔️ N+1 Capital makes first ever India investment, parks Rs 5 cr in Clensta
✔️ Cipla close to committing $1 billion advance for Moderna COVID-19 booster vaccine in India
✔️ Cipla says close to committing $1 billion to Moderna for booster vaccine
✔️ Close to commit over $1-b to Moderna for booster vaccine: Cipla to Govt
✔️ Cipla to market Delhi start-up's waterless' hygiene products
✔️ Cipla gets DCGI nod to import Moderna COVID-19 vaccine
✔️ Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
✔️ Cipla gets nod to import Moderna's covid vaccine for emergency use in India: Report
✔️ India's drug regulator may soon approve Moderna's vaccine: Report
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 25-05-2021 To 29-06-2021
-: Stock News :- CIPLA 25-05-2021 To 29-06-2021

✔️ Cipla's RT-PCR test kit 'ViraGen' to be sold from today
✔️ Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
✔️ Cipla says close to committing $1 billion to Moderna for booster vaccine
✔️ Close to commit over $1-b to Moderna for booster vaccine: Cipla to Govt
✔️ Cipla to market Delhi start-up's waterless' hygiene products
✔️ Cipla gets DCGI nod to import Moderna COVID-19 vaccine
✔️ Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
✔️ Cipla gets nod to import Moderna's covid vaccine for emergency use in India: Report
✔️ India's drug regulator may soon approve Moderna's vaccine: Report
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 24-05-2021 To 29-06-2021
-: Stock News :- CIPLA 24-05-2021 To 29-06-2021

✔️ Cipla, Roche launch covid-19 antibody cocktail at 59,750 per dose
✔️ Cipla launches Roche's Covid antibody cocktail in India for Rs 60k per dose
✔️ Roche's antibody cocktail launched in India at 59,750/dose
✔️ COVID-19 treatment: Roche, Cipla launch antibody cocktail Casirivimab and Imdevimab in India
✔️ Cipla to market Delhi start-up's waterless' hygiene products
✔️ Cipla gets DCGI nod to import Moderna COVID-19 vaccine
✔️ Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
✔️ Cipla gets nod to import Moderna's covid vaccine for emergency use in India: Report
✔️ India's drug regulator may soon approve Moderna's vaccine: Report
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 20-05-2021 To 29-06-2021
-: Stock News :- CIPLA 20-05-2021 To 29-06-2021

✔️ Cipla Launches Covid-19 Detection Test Kit ; Shares Gain
✔️ Cipla, Ubio Biotech launches RT-PCR test kit 'ViraGen' for Covid in India
✔️ Cipla launches RT-PCR test kit 'ViraGen' in India partnership with Ubio Biotech
✔️ Cipla share price gains on launching polymerase chain reaction test kit
✔️ Cipla launches COVID-19 real-time test kit 'ViraGen'; to be sold from May 25
✔️ Cipla launches polymerase chain reaction test kit ViraGen' for Covid-19
✔️ Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
✔️ Cipla gets nod to import Moderna's covid vaccine for emergency use in India: Report
✔️ India's drug regulator may soon approve Moderna's vaccine: Report
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 18-05-2021 To 29-06-2021
-: Stock News :- CIPLA 18-05-2021 To 29-06-2021

✔️ Analysts expect Cipla to return up to 30% from here on as India biz gains momentum
✔️ Coronavirus pandemic | Cipla to expand portfolio for COVID-19 drugs over next two months, says CFO
✔️ Cipla stock prices down on Q4 disappointment
✔️ Cipla While COVID scope continues, watch out for FY23
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 15-05-2021 To 29-06-2021
-: Stock News :- CIPLA 15-05-2021 To 29-06-2021

✔️ COVID-19: Supply of Remdesivir catching up with demand, says Cipla
✔️ Cipla says supply of Covid-19 drug remdesivir catching up with demand
✔️ India's Cipla says supply of COVID-19 drug remdesivir catching up with demand
✔️ Cipla While COVID scope continues, watch out for FY23
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 14-05-2021 To 29-06-2021
-: Stock News :- CIPLA 14-05-2021 To 29-06-2021

✔️ Cipla Consolidated March 2021 Net Sales at Rs 4,606.45 crore, up 5.26% Y-o-Y
✔️ Cipla Q4 profit up 73% at 412 crore
✔️ Cipla Q4 profit up 73% at Rs 412 cr, total revenue at Rs 4,606 cr
✔️ Cipla While COVID scope continues, watch out for FY23
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 12-05-2021 To 29-06-2021
-: Stock News :- CIPLA 12-05-2021 To 29-06-2021

✔️ Karnataka threatens action against Cipla and Jubilant
✔️ Cipla Q4 profit up 73% at 412 crore
✔️ Cipla Q4 profit up 73% at Rs 412 cr, total revenue at Rs 4,606 cr
✔️ Cipla While COVID scope continues, watch out for FY23
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 10-05-2021 To 29-06-2021
-: Stock News :- CIPLA 10-05-2021 To 29-06-2021

✔️ Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug
✔️ Covid treatment: Cipla gains on licensing pact with Eli Lilly
✔️ Cipla ties up with Eli Lilly to make, sell Baricitinib to treat COVID-19 patients in India
✔️ Cipla enters into licensing pact with Eli Lilly for Baricitinib drug
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 06-05-2021 To 29-06-2021
-: Stock News :- CIPLA 06-05-2021 To 29-06-2021

✔️ India approves Roche's antibody cocktail to treat COVID-19; Cipla to distribute the drug
✔️ Roche gets Emergency Use nod for Antibody Cocktail for mild-to-moderate Covid-19
✔️ Roche gets Indian regulator's nod for antibody cocktail to treat covid-19
✔️ Roche's COVID-19 antibody cocktail receives Emergency Use Authorisation, Cipla to distribute the drug
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 21-04-2021 To 29-06-2021
-: Stock News :- CIPLA 21-04-2021 To 29-06-2021

✔️ Buy Cipla: target of Rs 1100: Sharekhan
✔️ Roche gets Emergency Use nod for Antibody Cocktail for mild-to-moderate Covid-19
✔️ Roche gets Indian regulator's nod for antibody cocktail to treat covid-19
✔️ Roche's COVID-19 antibody cocktail receives Emergency Use Authorisation, Cipla to distribute the drug
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 19-04-2021 To 29-06-2021
-: Stock News :- CIPLA 19-04-2021 To 29-06-2021

✔️ Chhattisgarh may sue Cipla for not meeting remdesivir supply requirements
✔️ US respiratory portfolio to drive medium term sales growth for Cipla
✔️ Roche gets Indian regulator's nod for antibody cocktail to treat covid-19
✔️ Roche's COVID-19 antibody cocktail receives Emergency Use Authorisation, Cipla to distribute the drug
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 13-04-2021 To 29-06-2021
-: Stock News :- CIPLA 13-04-2021 To 29-06-2021

✔️ Cipla doubles Remdesivir production to meet 'unprecedented' demand
✔️ Cipla doubles remdesivir production to meet 'unprecedented' demand
✔️ Cipla doubles remdesivir production to meet 'unprecedented' demand
✔️ Roche's COVID-19 antibody cocktail receives Emergency Use Authorisation, Cipla to distribute the drug
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 12-04-2021 To 29-06-2021
-: Stock News :- CIPLA 12-04-2021 To 29-06-2021

✔️ Cipla Q4 PAT seen up 147.8% YoY to Rs. 609 cr: Sharekhan
✔️ Cipla doubles remdesivir production to meet 'unprecedented' demand
✔️ Cipla doubles remdesivir production to meet 'unprecedented' demand
✔️ Roche's COVID-19 antibody cocktail receives Emergency Use Authorisation, Cipla to distribute the drug
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 23-03-2021 To 29-06-2021
-: Stock News :- CIPLA 23-03-2021 To 29-06-2021

✔️ Cipla reappoints Umang Vohra as MD & Global CEO for 5 years
✔️ Cipla board approves reappointment of Umang Vohra as MD & Global CEO
✔️ Cipla board approves reappointment of Umang Vohra as MD & Global CEO for 5 years
✔️ Cipla arm partners US firm to develop novel antibiotics
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 06-03-2021 To 29-06-2021
-: Stock News :- CIPLA 06-03-2021 To 29-06-2021

✔️ Tech query: Cipla on a short-term downtrend
✔️ Cipla liquidates wholly-owned unit as part of internal reorganisation
✔️ Cipla liquidates wholly-owned unit as part of internal reorganisation
✔️ Cipla arm partners US firm to develop novel antibiotics
✔️ Cipla dips 4% on lower than expected March quarter earnings
✔️ Cipla share price falls 3% post Q4 earnings. Here's what brokerages say
✔️ Cipla share price down 3% after Q4 earnings misses expectations
✔️ Cipla open to forge a partnership to distribute Covid-19 vaccines in India
✔️ Cipla looks to expand its covid-19 portfolio over next two months
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 03-03-2021 To 29-06-2021
-: Stock News :- CIPLA 03-03-2021 To 29-06-2021

✔️ Cipla's Gulf arm to market, sell 4 biosimilar medicines in NZ, Australia
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 01-03-2021 To 29-06-2021
-: Stock News :- CIPLA 01-03-2021 To 29-06-2021

✔️ Cipla on a firm wicket; sustaining growth momentum, margins hold key
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 22-02-2021 To 29-06-2021
-: Stock News :- CIPLA 22-02-2021 To 29-06-2021

✔️ Cipla in talks to bring Covid antidotes to India
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 10-02-2021 To 29-06-2021
-: Stock News :- CIPLA 10-02-2021 To 29-06-2021

✔️ Cipla plans to double share from consumer health business in 5 years
✔️ Buy Cipla; target of Rs 940: Dolat Capital Market
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 08-02-2021 To 29-06-2021
-: Stock News :- CIPLA 08-02-2021 To 29-06-2021

✔️ Buy Cipla; target of Rs 950: Sharekhan
✔️ Buy Cipla; target of Rs 940: Dolat Capital Market
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 04-02-2021 To 29-06-2021
-: Stock News :- CIPLA 04-02-2021 To 29-06-2021

✔️ Accumulate Cipla; target of Rs 913: Prabhudas Lilladher
✔️ Buy Cipla; target of Rs 975: ICICI Direct
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 03-02-2021 To 29-06-2021
-: Stock News :- CIPLA 03-02-2021 To 29-06-2021

✔️ Pharma stocks rally after Rs 2.23 lakh-crore boost for healthcare sector; Cipla, Sun Pharma hit 52-week high
✔️ Buy Cipla; target of Rs 975: ICICI Direct
✔️ Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 02-02-2021 To 29-06-2021
-: Stock News :- CIPLA 02-02-2021 To 29-06-2021

✔️ Neutral Cipla; target of Rs 900: Motilal Oswal
✔️ Buy Cipla; target of Rs 1020: HDFC Securities
✔️ Cipla Consolidated December 2020 Net Sales at Rs 5,168.69 crore, up 18.25% Y-o-Y
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 30-01-2021 To 29-06-2021
-: Stock News :- CIPLA 30-01-2021 To 29-06-2021

✔️ How Cipla has performed
✔️ Buy Cipla; target of Rs 1020: HDFC Securities
✔️ Cipla Consolidated December 2020 Net Sales at Rs 5,168.69 crore, up 18.25% Y-o-Y
✔️ Cipla's new migraine drug Sumatriptan Nasal Spray gets USFDA approval
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 29-01-2021 To 29-06-2021
-: Stock News :- CIPLA 29-01-2021 To 29-06-2021

✔️ Cipla's net profit zooms 113% in December quarter; revenue up 18%
✔️ Cipla posts strong Q3 numbers, profit more than doubles to Rs 748.15 crore
✔️ Cipla Q3 results: Net profit jumps 113% to Rs 748 crore, beats Street estimates; revenue rises 18%
✔️ Cipla Q3 preview: Consolidated PAT seen rising 76% YoY aided by strong India, US ops
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 22-01-2021 To 29-06-2021
-: Stock News :- CIPLA 22-01-2021 To 29-06-2021

✔️ Cipla Q3 PAT seen up 74.3% YoY to Rs. 612 cr: Yash Securities
✔️ Cipla posts strong Q3 numbers, profit more than doubles to Rs 748.15 crore
✔️ Cipla Q3 results: Net profit jumps 113% to Rs 748 crore, beats Street estimates; revenue rises 18%
✔️ Cipla Q3 preview: Consolidated PAT seen rising 76% YoY aided by strong India, US ops
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 18-01-2021 To 29-06-2021
-: Stock News :- CIPLA 18-01-2021 To 29-06-2021

✔️ Cipla Q3 PAT seen up 77.2% YoY to Rs. 351 cr: Prabhudas Lilladher
✔️ Cipla posts strong Q3 numbers, profit more than doubles to Rs 748.15 crore
✔️ Cipla Q3 results: Net profit jumps 113% to Rs 748 crore, beats Street estimates; revenue rises 18%
✔️ Cipla Q3 preview: Consolidated PAT seen rising 76% YoY aided by strong India, US ops
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 10-01-2021 To 29-06-2021
-: Stock News :- CIPLA 10-01-2021 To 29-06-2021

✔️ Cipla recalls 5.8 lakh packets of gastric ulcer treatment drug from US market
✔️ Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
✔️ Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
✔️ Cipla Q3 preview: Consolidated PAT seen rising 76% YoY aided by strong India, US ops
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 07-01-2021 To 29-06-2021
-: Stock News :- CIPLA 07-01-2021 To 29-06-2021

✔️ After a late start, Cipla works to expand the global business
✔️ Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
✔️ Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
✔️ Cipla Q3 preview: Consolidated PAT seen rising 76% YoY aided by strong India, US ops
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 24-12-2020 To 29-06-2021
-: Stock News :- CIPLA 24-12-2020 To 29-06-2021

✔️ Top buy and sell ideas by Sudarshan Sukhani, Mitessh Thakkar for short term
✔️ Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
✔️ Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
✔️ Cipla Q3 preview: Consolidated PAT seen rising 76% YoY aided by strong India, US ops
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 16-12-2020 To 29-06-2021
-: Stock News :- CIPLA 16-12-2020 To 29-06-2021

✔️ Cipla launches rapid antigen detection 'CIPtest' for COVID-19 diagnosis
✔️ Cipla partners Premier Medical Corporation to launch COVID-19 rapid antigen test kits in India
✔️ Cipla, Premier Medical in tie-up to launch Covid-19 test kits in India
✔️ Cipla share price gains on launching rapid antigen detection test
✔️ Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand
✔️ Cipla Gulf expands partnership with Alvotech
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 14-12-2020 To 29-06-2021
-: Stock News :- CIPLA 14-12-2020 To 29-06-2021

✔️ Cipla share rises 5% after settlement with Celgene Corp
✔️ Buy Cipla; target of Rs 940: HDFC Securities
✔️ Buy Cipla; target of Rs 887: Prabhudas Lilladher
✔️ Cipla rallies 5% after settling litigation with Bristol Myers in US
✔️ Cipla Gains Nearly 5% On Settlement of US Patent Litigation
✔️ Cipla share price jumps 5% after settlement with Celgene Corp
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 11-12-2020 To 29-06-2021
-: Stock News :- CIPLA 11-12-2020 To 29-06-2021

✔️ Cipla settles blood cancer drug litigation with Bristol Myers in US
✔️ Buy Cipla; target of Rs 940: HDFC Securities
✔️ Buy Cipla; target of Rs 887: Prabhudas Lilladher
✔️ Cipla rallies 5% after settling litigation with Bristol Myers in US
✔️ Cipla Gains Nearly 5% On Settlement of US Patent Litigation
✔️ Cipla share price jumps 5% after settlement with Celgene Corp
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 07-12-2020 To 29-06-2021
-: Stock News :- CIPLA 07-12-2020 To 29-06-2021

✔️ Chronic portfolio may help Cipla sustain growth outperformance in near term
✔️ Buy Cipla; target of Rs 940: HDFC Securities
✔️ Buy Cipla; target of Rs 887: Prabhudas Lilladher
✔️ Cipla rallies 5% after settling litigation with Bristol Myers in US
✔️ Cipla Gains Nearly 5% On Settlement of US Patent Litigation
✔️ Cipla share price jumps 5% after settlement with Celgene Corp
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 18-11-2020 To 29-06-2021
-: Stock News :- CIPLA 18-11-2020 To 29-06-2021

✔️ Cipla enters pact with Belgium-based Multi-G to distribute 10 minute Covid-19 antibody test kit
✔️ Covid-19: Cipla in pact with Belgium firm to bring in rapid antibody test kit
✔️ Buy Cipla; target of Rs 887: Prabhudas Lilladher
✔️ Cipla rallies 5% after settling litigation with Bristol Myers in US
✔️ Cipla Gains Nearly 5% On Settlement of US Patent Litigation
✔️ Cipla share price jumps 5% after settlement with Celgene Corp
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 12-11-2020 To 29-06-2021
-: Stock News :- CIPLA 12-11-2020 To 29-06-2021

✔️ Hold Cipla; target of Rs 836: Prabhudas Lilladher
✔️ Covid-19: Cipla in pact with Belgium firm to bring in rapid antibody test kit
✔️ Buy Cipla; target of Rs 887: Prabhudas Lilladher
✔️ Cipla rallies 5% after settling litigation with Bristol Myers in US
✔️ Cipla Gains Nearly 5% On Settlement of US Patent Litigation
✔️ Cipla share price jumps 5% after settlement with Celgene Corp
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 11-11-2020 To 29-06-2021
-: Stock News :- CIPLA 11-11-2020 To 29-06-2021

✔️ Buy Cipla: target of Rs 950: Sharekhan
✔️ Covid-19: Cipla in pact with Belgium firm to bring in rapid antibody test kit
✔️ Buy Cipla; target of Rs 887: Prabhudas Lilladher
✔️ Cipla rallies 5% after settling litigation with Bristol Myers in US
✔️ Cipla Gains Nearly 5% On Settlement of US Patent Litigation
✔️ Cipla share price jumps 5% after settlement with Celgene Corp
✔️ Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
✔️ Cipla gets USFDA nod for migraine drug
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 09-11-2020 To 29-06-2021
-: Stock News :- CIPLA 09-11-2020 To 29-06-2021

✔️ Demand for Covid-19 drug Remdesivir rising sharply in India, says Cipla
✔️ Indian demand for COVID-19 drug Remdesivir rising sharply: Cipla
✔️ Buy Cipla; target of Rs 942: Dolat Capital Market
✔️ Buy Cipla; target of Rs 925: ICICI Direct
✔️ Cipla: Covid opportunity and traction for Albuterol strong positives; accumulate
✔️ Cipla expects surge in demand for respiratory drugs, inhalers in winter
✔️ Cipla asks its IT team to be on alert after cyber attacks on major pharma firms
✔️ Looking at sustaining growth through COVID-19 pandemic: Cipla
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 06-11-2020 To 29-06-2021
-: Stock News :- CIPLA 06-11-2020 To 29-06-2021

✔️ Cipla expects Q2 growth momentum to continue on back of India business, albuterol sales in US
✔️ Cipla Q2 results: Profit jumps 41% to Rs 665 crore, revenue up 15%
✔️ Cipla Q2 net profit up 39 per cent at Rs 659 cr
✔️ Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%
✔️ Cipla Q2 earnings beat street estimates; profit spikes 38% to Rs 662 crore, India sales up 17%
✔️ Cipla expects surge in demand for respiratory drugs, inhalers in winter
✔️ Cipla asks its IT team to be on alert after cyber attacks on major pharma firms
✔️ Looking at sustaining growth through COVID-19 pandemic: Cipla
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 28-10-2020 To 29-06-2021
-: Stock News :- CIPLA 28-10-2020 To 29-06-2021

✔️ Cipla gets into COVID-19 testing, with the launch of antibody test kits
✔️ Cipla Q2 results: Profit jumps 41% to Rs 665 crore, revenue up 15%
✔️ Cipla Q2 net profit up 39 per cent at Rs 659 cr
✔️ Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%
✔️ Cipla Q2 earnings beat street estimates; profit spikes 38% to Rs 662 crore, India sales up 17%
✔️ Cipla expects surge in demand for respiratory drugs, inhalers in winter
✔️ Cipla asks its IT team to be on alert after cyber attacks on major pharma firms
✔️ Looking at sustaining growth through COVID-19 pandemic: Cipla
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 14-10-2020 To 29-06-2021
-: Stock News :- CIPLA 14-10-2020 To 29-06-2021

✔️ Reduce Cipla; target of Rs 657: Prabhudas Lilladher
✔️ Cipla Q2 results: Profit jumps 41% to Rs 665 crore, revenue up 15%
✔️ Cipla Q2 net profit up 39 per cent at Rs 659 cr
✔️ Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%
✔️ Cipla Q2 earnings beat street estimates; profit spikes 38% to Rs 662 crore, India sales up 17%
✔️ Cipla expects surge in demand for respiratory drugs, inhalers in winter
✔️ Cipla asks its IT team to be on alert after cyber attacks on major pharma firms
✔️ Looking at sustaining growth through COVID-19 pandemic: Cipla
✔️ Cipla receives USFDA nod for nasal spray for treating migraine attacks
✔️ Cipla may import Moderna's COVID-19 vaccine; approval likely today
✔️ Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

View Full Story
-: Stock News :- CIPLA 28-06-2022 To 28-06-2022
-: Stock News :- CIPLA 28-06-2022 To 28-06-2022

✔️ Stocks to Watch: Tata Consumer, Cipla, Bank of Baroda

View Full Story
-: Stock News :- CIPLA 28-06-2022 To 27-06-2022
-: Stock News :- CIPLA 28-06-2022 To 27-06-2022

✔️ Cipla to invest Rs 26 crore in GoApptiv to raise stake to 22%
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%

View Full Story
-: Stock News :- CIPLA 17-06-2022 To 27-06-2022
-: Stock News :- CIPLA 17-06-2022 To 27-06-2022

✔️ Cipla to acquire 21% stake in diagnostic company Achira Labs for Rs 25 cr
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%

View Full Story
-: Stock News :- CIPLA 02-06-2022 To 27-06-2022
-: Stock News :- CIPLA 02-06-2022 To 27-06-2022

✔️ Cipla adds capacity of captive renewable energy power plant in Maharashtra, Karnataka
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%

View Full Story
-: Stock News :- CIPLA 20-05-2022 To 27-06-2022
-: Stock News :- CIPLA 20-05-2022 To 27-06-2022

✔️ Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%

View Full Story
-: Stock News :- CIPLA 19-05-2022 To 27-06-2022
-: Stock News :- CIPLA 19-05-2022 To 27-06-2022

✔️ Rejuvenating Cipla: After global expansion, acquisitions on cards
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%

View Full Story
-: Stock News :- CIPLA 07-08-2022 To 07-08-2022
-: Stock News :- CIPLA 07-08-2022 To 07-08-2022

✔️ Cipla betting big on digitisation and emerging segments like mRNA

View Full Story
-: Stock News :- CIPLA 01-08-2022 To 01-08-2022
-: Stock News :- CIPLA 01-08-2022 To 01-08-2022

✔️ Brokerages see up to 20% upside in Cipla post Q1 results; time to buy?

View Full Story
-: Stock News :- CIPLA 29-07-2022 To 29-07-2022
-: Stock News :- CIPLA 29-07-2022 To 29-07-2022

✔️ Cipla looking at products to treat monkey pox
✔️ Cipla Consolidated June 2022 Net Sales at Rs 5,375.19 crore, down 2.35% Y-o-Y
✔️ Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
✔️ Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%
✔️ Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%

View Full Story
-: Stock News :- CIPLA 28-07-2022 To 29-07-2022
-: Stock News :- CIPLA 28-07-2022 To 29-07-2022

✔️ Cipla Q1 revenue may be muted on high base, low Covid drug sales: Analysts
✔️ Cipla Consolidated June 2022 Net Sales at Rs 5,375.19 crore, down 2.35% Y-o-Y
✔️ Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
✔️ Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%
✔️ Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%

View Full Story
-: Stock News :- CIPLA 27-07-2022 To 29-07-2022
-: Stock News :- CIPLA 27-07-2022 To 29-07-2022

✔️ Board of large-cap pharma company Cipla fixes record date for 250% dividend
✔️ Cipla Consolidated June 2022 Net Sales at Rs 5,375.19 crore, down 2.35% Y-o-Y
✔️ Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
✔️ Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%
✔️ Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%

View Full Story
-: Stock News :- CIPLA 28-06-2022 To 29-07-2022
-: Stock News :- CIPLA 28-06-2022 To 29-07-2022

✔️ Cipla to invest Rs 26 crore in GoApptiv to raise stake to 22%
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%
✔️ Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
✔️ Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%
✔️ Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%

View Full Story
-: Stock News :- CIPLA 17-06-2022 To 29-07-2022
-: Stock News :- CIPLA 17-06-2022 To 29-07-2022

✔️ Cipla to acquire 21% stake in diagnostic company Achira Labs for Rs 25 cr
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%
✔️ Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
✔️ Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%
✔️ Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%

View Full Story
-: Stock News :- CIPLA 02-06-2022 To 29-07-2022
-: Stock News :- CIPLA 02-06-2022 To 29-07-2022

✔️ Cipla adds capacity of captive renewable energy power plant in Maharashtra, Karnataka
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%
✔️ Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
✔️ Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%
✔️ Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%

View Full Story
-: Stock News :- CIPLA 20-05-2022 To 29-07-2022
-: Stock News :- CIPLA 20-05-2022 To 29-07-2022

✔️ Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%
✔️ Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
✔️ Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%
✔️ Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%

View Full Story
-: Stock News :- CIPLA 19-05-2022 To 29-07-2022
-: Stock News :- CIPLA 19-05-2022 To 29-07-2022

✔️ Rejuvenating Cipla: After global expansion, acquisitions on cards
✔️ Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%
✔️ Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
✔️ Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%
✔️ Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%

View Full Story

No More Records...